You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 566 MDK-202: An empirically-designed peptidyl agonist of the IL-2/15βγc receptor, devoid of Rα interaction, unrelated to IL-2 or IL-15, and fused to an Fc-domain for PK enhancement

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
566 MDK-202: An empirically-designed peptidyl agonist of the IL-2/15βγc receptor, devoid of Rα interaction, unrelated to IL-2 or IL-15, and fused to an Fc-domain for PK enhancement

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dower W, Cwirla S, Williams B, et al
566 MDK-202: An empirically-designed peptidyl agonist of the IL-2/15βγc receptor, devoid of Rα interaction, unrelated to IL-2 or IL-15, and fused to an Fc-domain for PK enhancement
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0566